Junli Liu | Lipid Metabolism | Best Researcher Award

Dr. Junli Liu | Lipid Metabolism | Best Researcher Award 

Junli Liu, M.D., Ph.D., is an Associate Researcher and Deputy Chief Technologist at The First Affiliated Hospital of Xinxiang Medical University. Specializing in neurology, he focuses on metabolism, neurohomeostasis, and the effects of environmental exposure on neurodegenerative diseases. As a Master’s Supervisor, he actively contributes to clinical research, stroke genetics, and neuro-rehabilitation. He holds key positions in several medical associations and has published extensively in leading scientific journals. His work integrates clinical epidemiology and molecular biology to advance neurological research and patient care.

Dr. Junli Liu | The First Affiliated Hospital of Xinxiang Medical University | China

Profile

SCOPUS ID

🎓Education

  • Junli Liu holds a Medical Doctor (M.D.) degree and a Ph.D. in Neurology, specializing in clinical research and neuropathology. With a strong academic foundation, he has advanced expertise in the study of neurological disorders, metabolism, and neurohomeostasis.

👨‍🏫Experience

  • Currently serving as an Associate Researcher and Deputy Chief Technologist at The First Affiliated Hospital of Xinxiang Medical University, Junli Liu plays a vital role in medical research and clinical practice. He is also a Master’s Supervisor in Neurology at Xinxiang Medical University, guiding postgraduate students in their academic and professional development. His expertise extends to clinical epidemiology, stroke genetics, and neuro-rehabilitation, contributing significantly to national and provincial scientific projects.

🏆Awards and Recognitions

  • Junli Liu has earned recognition for his contributions to neurology and medical research through active participation in prestigious scientific committees and associations. He holds key positions such as a Standing Committee Member of the Stroke and Genetics Branch of the Henan Stroke Association and a Youth Committee Member of the Clinical Epidemiology and Evidence-Based Medicine Branch of the Henan Medical Association. His research and leadership have significantly influenced advancements in stroke genetics and neurohomeostasis.

💡Skills and Certifications

  • With a deep understanding of neuropathology, Junli Liu specializes in metabolism and neurohomeostasis, environmental exposure, and neurodegenerative diseases. His research integrates clinical epidemiology, advanced proteomics, and molecular biology to explore the underlying mechanisms of neurological disorders. His technical skills encompass clinical research methodologies, data analysis, and evidence-based medicine, contributing to innovative medical solutions and improved patient care.

🔬 Research Focus

  • Junli Liu’s research primarily revolves around metabolism and neurohomeostasis, emphasizing how metabolic imbalances contribute to neurological disorders. He also investigates the impact of environmental exposure on neurodegenerative diseases, shedding light on factors that influence cognitive decline and neural health. His publications cover diverse topics, including diabetes-induced endoplasmic reticulum stress, cerebral small vessel disease, vascular injury mechanisms, and the protective effects of neuroactive compounds. Through his extensive studies, he strives to enhance understanding and treatment strategies for neurological conditions.

🌎Conclusion

  • Dr. Junli Liu stands out as an exceptional researcher in neurology, with significant contributions to stroke genetics, neurodegenerative diseases, and neurohomeostasis. His extensive publication record in high-impact journals, leadership roles in prestigious medical associations, and active involvement in national and provincial research projects demonstrate his commitment to advancing neurological science and clinical research.

📖Publications

  • Thioredoxin 1 overexpression attenuated diabetes‐induced endoplasmic reticulum stress in Müller cells via apoptosis signal‐regulating kinase 1
    Authors: X. Yu, Q. Teng, K. Bao, M. Chudhary, H. Qi, W. Zhou, H. Che, J. Liu, X. Ren, L. Kong
    Journal: Journal of Cellular Biochemistry, 2023

  • The correlation between the severity of cerebral microbleeds and serum HMGB1 levels and cognitive impairment in patients with cerebral small vessel disease
    Authors: M. Wang, J. Liu, F. Wang, Q. Li, J. Zhang, S. Ji, S. Li, C. Lu, J. Zhao
    Journal: Frontiers in Aging Neuroscience, 2023

  • Proteomics-based evaluation of the mechanism underlying vascular injury via DNA interstrand crosslinks, glutathione perturbation, mitogen-activated protein kinase, and Wnt and ErbB signaling pathways induced by crotonaldehyde
    Authors: M.-Z. Xie, J.-L. Liu, Q.-Z. Gao, D.-Y. Bo, L. Wang, X.-C. Zhou, M.-M. Zhao, Y.-C. Zhang, Y.-J. Zhang, G.-A. Zhao, L.-Y. Jiao
    Journal: Clinical Proteomics, 2022

  • Protective effect of Liraglutide on diabetic retinal neurodegeneration via inhibiting oxidative stress and endoplasmic reticulum stress
    Authors: J. Liu, L. Wei, Z. Wang, S. Song, Z. Lin, J. Zhu, X. Ren, L. Kong
    Journal: Neurochemistry International, 2020

  • Triterpenoids from functional mushroom Ganoderma resinaceum and the novel role of Resinacein S in enhancing the activity of brown/beige adipocytes
    Authors: Y. Huang, G. Wei, X. Peng, G. Hu, H. Su, J. Liu, X. Chen, M. Qiu
    Journal: Food Research International, 2020